Hepatic masses in children: a 15-year experience at a single tertiary care center in India
DOI:
https://doi.org/10.18203/2349-3291.ijcp20251865Keywords:
Hepatic masses, Histopathology, Chemotherapy, Liver transplantationAbstract
Background: Hepatic masses are rare and challenging to diagnose and manage in pediatric populations; therefore, data on clinical presentation, management strategies, and long-term outcomes are limited. Hence, the aim of the study was to review the incidence, clinical spectrum, management, and outcome of hepatic masses in pediatrics.
Methods: This retrospective, cross-sectional study reviewed the medical records of pediatric patients (age <18 years) presenting to a pediatric hepatologist and diagnosed with hepatic masses between 2010 and 2024 at a tertiary care center.
Results: Thirty-nine patients were identified with hepatic masses, 21 (53.8%) had benign tumors and 18 (46.2%) had malignant tumors. The median age of patients was 39 months (range: 2–208 months) at presentation, and 19 (48.7%) of them were females. The most common presentation is abdominal distension (n=14, 35.8%), while the less frequent presentations were abdominal pain (n=6, 15.38%), pallor (n=6, 15.38 %) and anorexia (n=4, 10.20%). Hepatic masses were an incidental finding in 5 patients (12.80%). Patients underwent different radiologic investigations including ultrasound imaging (n=15, 38.4%), computed tomography (CT; n=26, 66.6%), magnetic resonance imaging (MRI; n=8, 20.5%), and positron emission tomography (PET; n=11, 28.2%). Histopathology was done preoperatively in 9 (23.07%) patients and post operatively in 17 (43.5%) patients. Most patients underwent surgical resection (n=16, 41%), 5 (12.8%) patients received chemotherapy for malignant tumors, and 5 (12.8%) patients underwent liver transplantation. Surgical complications occurred in 2 (5.1%) patients but were successfully managed. One patient was lost to follow up and no mortality was reported in the remaining patients with long-term follow up.
Conclusion: The immediate and long-term clinical outcomes of surgical resection and liver transplantation, with or without chemotherapy, are good without considerable morbidity or mortality. This study contributes valuable real-world data to inform clinical practice and future research in this area.
Metrics
References
Franchi-Abella S, Branchereau S. Benign hepatocellular tumors in children: focal nodular hyperplasia and hepatocellular adenoma. Int J Hepatol. 2013;2:1-11. DOI: https://doi.org/10.1155/2013/215064
Kelgeri C, Renz D, McGuirk S, Schmid I, Sharif K, Baumann U. Liver tumours in children: the hepatologist’s view. J Pediatr Gastroenterol Nutr. 2021;72(4):487-93. DOI: https://doi.org/10.1097/MPG.0000000000003006
Lucas B, Ravishankar S, Pateva I. Pediatric primary hepatic tumors: diagnostic considerations. Diagnostics (Basel). 2021;11(2):333. DOI: https://doi.org/10.3390/diagnostics11020333
Cekuolis A, Schreiber-Dietrich D, Augustinienė R, et al. Incidental findings in pediatric patients: how to manage liver incidentaloma in pediatric patients. Cancers (Basel). 2023;15(8):2360. DOI: https://doi.org/10.3390/cancers15082360
Karmazyn B, Rao GS, Johnstone LS. Diagnosis and follow‐up of incidental liver lesions in children. J Pediatr Gastroenterol Nutr. 2022;74(3):320-7. DOI: https://doi.org/10.1097/MPG.0000000000003377
Fuchs J, Warmann SW, Urla C, Schäfer JF, Schmidt A. Management of benign liver tumors. Semin Pediatr Surg. 2020;29(4):150941. DOI: https://doi.org/10.1016/j.sempedsurg.2020.150941
Meyers R, Hiyama E, Czauderna P, Tiao GM. Liver tumors in pediatric patients. Surg Oncol Clin N Am. 2021;30(2):253-74. DOI: https://doi.org/10.1016/j.soc.2020.11.006
Venkatesh SK, Chandan V, Roberts LR. Liver masses: a clinical, radiologic, and pathologic perspective. Clin Gastroenterol Hepatol. 2014;12(9):1414-29. DOI: https://doi.org/10.1016/j.cgh.2013.09.017
Qureshi SS, Bhagat M, Kembhavi S. Benign liver tumors in children: outcomes after resection. Pediatr Surg Int. 2015;31(12):1145-9. DOI: https://doi.org/10.1007/s00383-015-3763-3
Gontumukkala C, Teja R. Benign liver tumors in children-single centre experience. Int Surg J. 2017;5(1):143. DOI: https://doi.org/10.18203/2349-2902.isj20175884
Ray G, Das K, Sarkar A, Bose D, Halder P. Propranolol monotherapy in multifocal/diffuse infantile hepatic hemangiomas in Indian children: a case series. J Clin Exp Hepatol. 2023;13(4):707-12 DOI: https://doi.org/10.1016/j.jceh.2023.02.005
Islam N, Halder A, Ghosh R, Banerjee S, Mishra P, Chatterjee U. Focal nodular hyperplasia of the liver in children: a report of 2 cases. Indian J Pathol Microbiol. 2019;62(2):261. DOI: https://doi.org/10.4103/IJPM.IJPM_396_18
Shukla PJ, Barreto SG, Qureshi SS. Hepatoblastoma: a single institutional experience of 18 cases. Pediatr Surg Int. 2008;24(7):799-802 DOI: https://doi.org/10.1007/s00383-008-2169-x
Singh T, Satheesh C, Appaji L. Hepatoblastoma: experience from a single center. Indian J Cancer. 2010;47(3):314. DOI: https://doi.org/10.4103/0019-509X.64724
Shanmugam N, Scott JX, Kumar V. Multidisciplinary management of hepatoblastoma in children: experience from a developing country. Pediatr Blood Cancer. 2017;64(3):26249 DOI: https://doi.org/10.1002/pbc.26249
Dhali A, Mandal TS, Das S. Clinical profile of hepatoblastoma: experience from a tertiary care centre in a resource-limited setting. Cureus. 2022;14(7):26494. DOI: https://doi.org/10.7759/cureus.26494
Pandey A, Gangopadhyay A, Sharma S. Long-term follow-up of mesenchymal hamartoma of liver – single center study. Saudi J Gastroenterol. 2011;17(1):20 DOI: https://doi.org/10.4103/1319-3767.74449
Muthuvel E. A clinicopathological study of paediatric liver tumours in a tertiary care hospital. J Clin Diagn Res. 2017;11(4):14-6. DOI: https://doi.org/10.7860/JCDR/2017/24223.9592
Ayllo M, Tamire A, Legas M, Arega G. Patterns and clinico-radiological characteristics of primary liver masses in children treated at a tertiary referral hospital, in Ethiopia. Pediatr Health Med Ther. 2023;14:455-64. DOI: https://doi.org/10.2147/PHMT.S433460
Bajenaru N, Balaban V, Săvulescu F, Campeanu I, Patrascu T. Hepatic hemangioma–review. J Med Life. 2015;8(2):4-11.
Kochin IN, Miloh TA, Arnon R, Iyer KR, Suchy FJ, Kerkar N. Benign liver masses and lesions in children: 53 cases over 12 years. ISR Med Assoc J. 2011;13(9):542-7.
Mittal S, Singh S, Batra R. Imaging appearances of pediatric hepatic masses−a review. MAMC J Med Sci. 2020;6(3):176. DOI: https://doi.org/10.4103/mamcjms.mamcjms_76_20
Al Tasseh F, El‐Khansa M, Abd O, Abdel Khalek A, El‐Rifai N. Diffuse hepatic hemangioma with single cutaneous hemangioma: an alerting occurrence. Clin Case Rep. 2017;5(6):887-90. DOI: https://doi.org/10.1002/ccr3.963
Thyagarajan MS, Sharif K. Space occupying lesions in the liver. Indian J Pediatr. 2016;83(11):1291-302. DOI: https://doi.org/10.1007/s12098-016-2240-x
Shayan YR, Prendiville JS, Goldman RD. Use of propranolol in treating hemangiomas. Can Fam Physician. 2011;57(3):302-3.
Tian R, Liang Y, Wang J. Propranolol for infantile hepatic hemangioendothelioma: clinical evaluation of drug efficacy and safety using a single-center patient cohort. Ann Hepatol. 2020;19(5):530-4. DOI: https://doi.org/10.1016/j.aohep.2020.04.008
Léauté-Labrèze C, De La Roque ED, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-51. DOI: https://doi.org/10.1056/NEJMc0708819
Siano MA, Ametrano O, Barbato F. Consumptive hypothyroidism due to hepatic hemangiomas: a case series and review of the literature. JPGN Rep. 2022;3(4):270. DOI: https://doi.org/10.1097/PG9.0000000000000270
Çetinkaya S, Kendirci HNP, Ağladıoğlu SY. Hypothyroidism due to hepatic hemangioendothelioma: a case report. J Clin Res Pediatr Endocrinol. 2010;2(3):126-30. DOI: https://doi.org/10.4274/jcrpe.v2i3.126
Zhang X, Ren W, Song G, Xiao Y, Sun F, Wang N. Infantile hepatic hemangiomas associated with high-output cardiac failure and pulmonary hypertension. BMC Cardiovasc Disord. 2019;19(1):216. DOI: https://doi.org/10.1186/s12872-019-1200-6
Chiorean L. Benign liver tumors in pediatric patients–review with emphasis on imaging features. World J Gastroenterol. 2015;21(28):8541-53. DOI: https://doi.org/10.3748/wjg.v21.i28.8541
Valentino PL, Ling SC. The role of diagnostic imaging and liver biopsy in the diagnosis of focal nodular hyperplasia in children. Liver Int. 2014;34(2):227-34. DOI: https://doi.org/10.1111/liv.12241
Marwah S, Mustafizur Rahman Khan M, Chaudhary A, et al. Two hundred and forty-one consecutive liver resections: an experience from India. HPB (Oxford). 2007;9(1):29-36. DOI: https://doi.org/10.1080/13651820600985259
Patkar S, Parray A, Kanetkar A, Shetty N, Kulkarni S, Goel M. Towards standardization of liver resections in India: five hundred consecutive oncological liver resections – trends, techniques and outcomes. J Gastrointest Cancer. 2021;52(2):651-8. DOI: https://doi.org/10.1007/s12029-020-00444-6
Arora RS. Outcomes of hepatoblastoma in the Indian context. Indian Pediatr. 2012;49(4):307-9. DOI: https://doi.org/10.1007/s13312-012-0037-1
Zsíros J, Maibach R, Shafford E. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3 hours study. J Clin Oncol. 2010;28(15):2584-90. DOI: https://doi.org/10.1200/JCO.2009.22.4857
Grimaldi C, Goyet J, Bici K, Cianci MC, Callea F, Morabito A. The role of liver transplantation in the care of primary hepatic vascular tumours in children. Front Oncol. 2022;12:1026232. DOI: https://doi.org/10.3389/fonc.2022.1026232
Rao S, D′Cruz AL, Aggarwal R. Pediatric liver transplantation: a report from a pediatric surgical unit. J Indian Assoc Pediatr Surg. 2011;16(1):2-5. DOI: https://doi.org/10.4103/0971-9261.74512
Głowska-Ciemny J, Szymanski M, Kuszerska A, Rzepka R, Von Kaisenberg CS, Kocyłowski R. Role of alpha-fetoprotein (AFP) in diagnosing childhood cancers and genetic-related chronic diseases. Cancers (Basel). 2023;15(17):4302. DOI: https://doi.org/10.3390/cancers15174302
Downloads
Published
How to Cite
Issue
Section
